The invention relates to a dragon fish white-eye disease treatment liquid, which is characterized by comprising the following components in parts by weight: 1 to 2 parts of gentamicin sulfate, 3 to 5 parts of ethyl paraben, 5 to 8 parts of nitrofurazone, 5 to 10 parts of bendazac lysine, 5 to 10 parts of sodium chloride (NaCl), and 20 to 30 parts of traditional Chinese medicine liquid, wherein the traditional Chinese medicine liquid is prepared by boiling the following traditional Chinese herbals in water (50 to 60 parts by weight): 2 to 5 parts of cassia seed, 2 to 4 parts of wild chrysanthemum, 3 to 4 parts of inula flower, and 1 to 2 parts of Chinese milk vetch. The treatment liquid is prepared by adding gentamicin sulfate, ethyl paraben, nitrofurazone, bendazac lysine, and NaCl into the traditional Chinese medicine liquid and evenly mixing.